xoma to sell Raptiva royalties to "investors"...Top that!!!
Forget Raptiva $6.2 millions in sales (Gw, Dna reported that long ago), or the $0.2M REVENUES !!!
How much does xoma gets from Alexion? Top (Alex needs xoma's antibody technology, nothing new, and xoma will give it up for nothing new)!
Well, let's be optimistic, Amgen could not figure out the platelets business cause they were so smart that they gave it to healthy subjects to create lots for the transfusion business, then the subject got thrombosis, and then the Fda said folgedaaboudid!
Now, Alex the big one comes to the rescue, kind of let's give it to the people who needs it in the first place the ones with low platelets, better for the chemotherapy ones cause you know the cause and they take a while before bleeding and then one has some time to kick in with an stimulating mab (xoma give the engineering, Alex the receptor, and alex gets the money...oops, I did it again, could not stay positve one second... xoma also gets some money...like pdli and tnox do from CLEAN royalties, not bad (for pdli and tnox), But, not for xoma, logic is not working (even Gw short is working):
...Then xoma to finance the Top, will sell the Raptiva royalties to some "investors", a good business, since they will get $12M for the 25%, brilliant!
ING1 officially dead, sorry Rk. |
